ESR1 and breast carcinoma: Moreover, upon comparing differentially methylated breast cancer cell lines for WA responsive target genes with DNA methylation changes in different clinical subtypes of BC patients in the cancer genome atlas (TCGA), it was found that WA silences HER2/PR/ER dependent gene expression programs in primary BC.